New pathogenic paradigms in inflammatory bowel disease.


Recent progresses in basic science have opened new pathogenic scenarios in inflammatory bowel disease. The T helper cell type (Th)1/Th2 paradigm has been outdated thanks to the advances in understanding the function of Th17 cells. Innate immunity, nonimmune cells, and defective tolerogenic mechanisms play a no less crucial role than do adaptive immunity, immune cells, and hyperactivation of effector mechanisms. These new paradigms, together with the no longer "static" but "dynamic" vision of intestinal inflammation, highlight new possible therapeutic targets in inflammatory bowel disease.

DOI: 10.1002/ibd.21735
Citations per Year

136 Citations

Semantic Scholar estimates that this publication has 136 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Sabatino2012NewPP, title={New pathogenic paradigms in inflammatory bowel disease.}, author={Antonio Di Sabatino and Paolo Biancheri and Laura Rovedatti and Thomas Thornton Macdonald and Gino Roberto Corazza}, journal={Inflammatory bowel diseases}, year={2012}, volume={18 2}, pages={368-71} }